| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Arrhythmia | |||||
| Cardiovascular Diseases | |||||
| Coronary Disease | |||||
| Death, Sudden, Cardiac | |||||
| Heart Diseases | |||||
| Myocardial Infarction | |||||
| Myocardial Ischemia | |||||
| Ventricular Fibrillation | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arrhythmias, Cardiac | |||||
| Death, Sudden | |||||
| Infarction | |||||
| Ischemia | |||||
| 3 | More general conditions related to this trial | ||||
| Death | |||||
| Heart Arrest | |||||
| Necrosis | |||||
| Pathologic Processes | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| propranolol | |||||
| 5 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic Antagonists | |||||
| Adrenergic beta-Antagonists | |||||
| Anti-Arrhythmia Agents | |||||
| Antihypertensive Agents | |||||
| Cardiovascular Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
|
